Biomedical Engineering Reference
In-Depth Information
74. Carter P, Presta L, Gorman CM, Ridgway JB, Henner D, Wong
WL, et al. (1992) Humanization of an anti-p185HER2 anti-
body for human cancer therapy. Proc. Natl. Acad. Sci. USA 89
(10), 4285-4289.
75. Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V,
Bajamonde A, et al. (2001) Use of chemotherapy plus a
monoclonal antibody against HER2 for metastatic breast
cancer that overexpresses HER2. N. Engl. J. Med. 344(11),
783-792.
76. Vogel CL, Cobleigh MA, Tripathy D, Gutheil JC, Harris LN,
Fehrenbacher L, et al. (2002) Efficacy and safety of trastuzu-
mab as a single agent in first-line treatment of HER2-over-
expressing metastatic breast cancer. J. Clin. Oncol. 20(3),
719-726.
77. Krauss WC, Park JW, Kirpotin DB, Hong K, Benz CC. (2000)
Emerging antibody-based HER2 (ErbB-2/neu) therapeutics.
Breast Dis. 11, 113-124.
78. Untch M, Himsl I, Kahlert S, Lueck HJ, Eidtmann H, Du Bois
A, et al. (2004) Anthracycline and trastuzumab in breast cancer
treatment. Oncology (Williston Park) 18(14 Suppl 14), 59-64.
79. Ma Z, Li Q, An H, Pankonin MS, Wang J, Loeb JA. (2009)
Targeting human epidermal growth factor receptor signaling
with the neuregulin's heparin-binding domain. J. Biol. Chem.
284(46), 32108-32115.
80. Nave KA, Salzer JL. (2006) Axonal regulation of myelination
by neuregulin 1. Curr. Opin. Neurobiol. 16(5), 492-500.
81. Jessen KR, Mirsky R. (2005) The origin and development of
glial cells in peripheral nerves. Nat. Rev. Neurosci. 6, 671-681.
82. Pankonin MS, Sohi J, Kamholz J, Loeb JA. (2009) Differential
distribution of neuregulin in human brain and spinal fluid.
Brain Res. 1258, 1-11.
83. Calvo M, Zhu N, Tsantoulas C, Ma Z, Grist J, Loeb JA, et al.
(2010) Neuregulin-ErbB signaling promotes microglial prolif-
eration and chemotaxis contributing to microgliosis and pain
after peripheral nerve injury. J. Neurosci. 30(15), 5437-5450.
84. Calvo M, Zhu N, Grist J, Ma Z, Loeb JA, Bennett DL. (2011)
Following nerve injury neuregulin-1 drives microglial prolif-
eration and neuropathic pain via the MEK/ERK pathway. Glia.
59(4), 554-568.
Search WWH ::
Custom Search